ADVENT CAPITAL MANAGEMENT /DE/ - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 19 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ADVENT CAPITAL MANAGEMENT /DE/ ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q2 2021$2,0000.0%2,0000.0%0.00%
Q1 2021$2,000
-100.0%
2,000
-100.0%
0.00%
-100.0%
Q3 2020$8,064,000
+2.3%
7,777,000
+8.6%
0.18%
-3.8%
Q2 2020$7,883,000
+48.7%
7,159,000
+35.5%
0.18%
+60.9%
Q1 2020$5,301,000
+1643.8%
5,283,000
+1893.6%
0.12%
+1816.7%
Q4 2019$304,000
-98.5%
265,000
-98.5%
0.01%
-98.4%
Q3 2019$20,261,000
+58.9%
17,756,000
+65.2%
0.38%
+53.8%
Q2 2019$12,751,000
-25.4%
10,746,000
-15.0%
0.25%
-34.5%
Q1 2019$17,103,000
-63.9%
12,649,000
-71.3%
0.38%
-67.1%
Q4 2018$47,388,000
-36.9%
44,032,000
-38.2%
1.15%
-25.9%
Q3 2018$75,071,000
+13.4%
71,231,000
+5.6%
1.55%
+11.1%
Q2 2018$66,181,000
+37.3%
67,450,000
+38.8%
1.39%
+47.1%
Q1 2018$48,198,000
+59.8%
48,598,000
+70.3%
0.95%
+63.7%
Q4 2017$30,156,000
-25.2%
28,544,000
-24.9%
0.58%
-24.3%
Q3 2017$40,330,000
-6.0%
38,030,000
-5.7%
0.76%
-6.9%
Q2 2017$42,924,000
-37.9%
40,312,000
-43.7%
0.82%
-36.5%
Q1 2017$69,095,000
+5.5%
71,584,000
+10.9%
1.29%
+7.3%
Q4 2016$65,482,000
-1.2%
64,541,000
-9.1%
1.20%
+25.8%
Q3 2016$66,281,000
+31.7%
70,972,000
+0.2%
0.96%
+22.8%
Q2 2016$50,346,000
-32.5%
70,827,000
-13.2%
0.78%
-31.5%
Q1 2016$74,545,000
+24.5%
81,578,000
+52.0%
1.14%
+23.4%
Q4 2015$59,882,00053,683,0000.92%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2021
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders